Published in Br J Nutr on June 04, 2010
Vascular dysfunction induced in offspring by maternal dietary fat involves altered arterial polyunsaturated fatty acid biosynthesis. PLoS One (2012) 1.00
Consequences of essential fatty acids. Nutrients (2012) 0.99
Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men. Diabetes Care (2013) 0.88
Fatty Acids Composition of Vegetable Oils and Its Contribution to Dietary Energy Intake and Dependence of Cardiovascular Mortality on Dietary Intake of Fatty Acids. Int J Mol Sci (2015) 0.85
Benefits of foods supplemented with vegetable oils rich in α-linolenic, stearidonic or docosahexaenoic acid in hypertriglyceridemic subjects: a double-blind, randomized, controlled trail. Eur J Nutr (2014) 0.81
A case-control study between gene polymorphisms of polyunsaturated fatty acid metabolic rate-limiting enzymes and acute coronary syndrome in Chinese Han population. Biomed Res Int (2013) 0.79
Role of genetic changes in the progression of cardiovascular diseases. Int J Biomed Sci (2011) 0.77
Application of Chemoenzymatic Hydrolysis in the Synthesis of 2-Monoacylglycerols. Tetrahedron (2012) 0.77
Interleukin-6 gene polymorphisms, dietary fat intake, obesity and serum lipid concentrations in black and white South African women. Nutrients (2014) 0.77
Impact of omega-6 fatty acids on cardiovascular outcomes: A review. J Preventive Cardiol (2013) 0.77
Dietary Intake and Weight Gain Among Adolescents on Depot Medroxyprogesterone Acetate. J Pediatr Adolesc Gynecol (2014) 0.76
Plasma linoleic acid partially mediates the association of bipolar disorder on self-reported mental health scales. J Psychiatr Res (2015) 0.76
Dietary fatty acids and inflammatory markers in patients with coronary artery disease. Adv Biomed Res (2014) 0.75
Associations between long chain polyunsaturated fatty acids and cardiovascular lipid risk factors in youth with type 1 diabetes: SEARCH Nutrition Ancillary Study. J Diabetes Complications (2016) 0.75
Pretreatment with n-6 PUFA protects against subsequent high fat diet induced atherosclerosis--potential role of oxidative stress-induced antioxidant defense. Atherosclerosis (2011) 0.75
Evening primrose oil ameliorates platelet aggregation and improves cardiac recovery in myocardial-infarct hypercholesterolemic rats. Int J Physiol Pathophysiol Pharmacol (2014) 0.75
Effects of the Dietary ω3:ω6 Fatty Acid Ratio on Body Fat and Inflammation in Zebrafish (Danio rerio). Comp Med (2015) 0.75
Baseline plasma fatty acids profile and incident cardiovascular events in the SU.FOL.OM3 trial: the evidence revisited. PLoS One (2014) 0.75
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet (2003) 11.67
Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology (2005) 7.03
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J (2013) 3.58
Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology (2008) 3.15
Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell (2009) 2.60
Genome sequence of an Australian kangaroo, Macropus eugenii, provides insight into the evolution of mammalian reproduction and development. Genome Biol (2011) 2.18
High intestinal cholesterol absorption is associated with cardiovascular disease and risk alleles in ABCG8 and ABO: evidence from the LURIC and YFS cohorts and from a meta-analysis. J Am Coll Cardiol (2013) 2.15
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial. Hepatology (2010) 2.13
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers. Cancer Res (2010) 2.06
Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab (2002) 1.98
Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol (2010) 1.98
Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation (2002) 1.92
Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology (2008) 1.91
Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol (2009) 1.87
First-pass and steady-state MR angiography of thoracic vasculature in children and adolescents. JACC Cardiovasc Imaging (2010) 1.74
Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J (2004) 1.71
Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab (2004) 1.70
A supramolecular assembly formed by influenza A virus genomic RNA segments. Nucleic Acids Res (2011) 1.65
The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood (2009) 1.63
Low-field magnetic resonance imaging: increased safety for pacemaker patients? Europace (2010) 1.57
Dual-source parallel radiofrequency excitation body MR imaging compared with standard MR imaging at 3.0 T: initial clinical experience. Radiology (2010) 1.54
A comprehensive description of muscle symptoms associated with lipid-lowering drugs. Cardiovasc Drugs Ther (2004) 1.53
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody. Circ Cardiovasc Genet (2015) 1.50
Cognitive trajectory after transcatheter aortic valve implantation. Circ Cardiovasc Interv (2013) 1.44
Intake of added oils and fats among middle-aged French adults: relationships with educational level and region of residence. J Am Diet Assoc (2005) 1.42
Apo-Hsp90 coexists in two open conformational states in solution. Biol Cell (2008) 1.39
Feasibility of outpatient coronary angiography with "ad hoc" angioplasty. Arch Cardiovasc Dis (2008) 1.38
Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas (2008) 1.31
Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T. Am Heart J (2011) 1.30
Evolutionary divergence of enzymatic mechanisms for posttranslational polyglycylation. Cell (2009) 1.28
Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc Natl Acad Sci U S A (2005) 1.28
Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state. J Cell Sci (2013) 1.24
Is serum cystatin-C a reliable marker for metabolic syndrome? Am J Med (2008) 1.24
Adiponutrin: A new gene regulated by energy balance in human adipose tissue. J Clin Endocrinol Metab (2004) 1.23
Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J Immunol (2008) 1.21
Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20
The inner mitochondrial membrane has aquaporin-8 water channels and is highly permeable to water. J Biol Chem (2005) 1.15
Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla. Pacing Clin Electrophysiol (2009) 1.13
Quantitative imaging of myocardial infarct in rats with high resolution pinhole SPECT. Int J Cardiovasc Imaging (2006) 1.10
An in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus. Nucleic Acids Res (2012) 1.10
Genomic anatomy of the Tyrp1 (brown) deletion complex. Proc Natl Acad Sci U S A (2006) 1.07
tmRNA-SmpB: a journey to the centre of the bacterial ribosome. EMBO J (2010) 1.06
Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy. Pharmacogenomics (2008) 1.06
Dual-source radiofrequency transmission with patient-adaptive local radiofrequency shimming for 3.0-T cardiac MR imaging: initial experience. Radiology (2012) 1.05
Accommodation of tmRNA-SmpB into stalled ribosomes: a cryo-EM study. RNA (2009) 1.04
Patients' and physicians' perceptions and experience of hypercholesterolaemia: a qualitative study. Br J Gen Pract (2003) 1.03
Visualization of cell microtubules in their native state. Biol Cell (2007) 1.02
Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli. J Virol (2002) 1.02
High-resolution myocardial stress perfusion at 3 T in patients with suspected coronary artery disease. Eur Radiol (2007) 1.01
Molecular basis of cytokine receptor activation. IUBMB Life (2010) 1.01
Structure of the mature P3-virus particle complex of cauliflower mosaic virus revealed by cryo-electron microscopy. J Mol Biol (2004) 1.01
Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. Atherosclerosis (2007) 1.01
Structural characterization of HC-Pro, a plant virus multifunctional protein. J Biol Chem (2003) 0.99
Comparative value of tissue Doppler imaging and m-mode color Doppler mitral flow propagation velocity for the evaluation of left ventricular filling pressure. Chest (2005) 0.99
Interaction network linking the human H3N2 influenza A virus genomic RNA segments. Vaccine (2012) 0.98
Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML. Blood (2009) 0.97
Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk. Arterioscler Thromb Vasc Biol (2003) 0.97
Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease). Orphanet J Rare Dis (2011) 0.96
Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism. Diabetes Care (2011) 0.96
Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles. Virology (2011) 0.95
Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives. Clin Chem Lab Med (2004) 0.95
Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2011) 0.95
Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke (2014) 0.95
Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patients. Fundam Clin Pharmacol (2006) 0.94
Lack of serologic evidence of Neospora caninum in humans, England. Emerg Infect Dis (2008) 0.94
Descending thoracic and thoracoabdominal aortic aneurysm in patients with Takayasu's disease. Ann Vasc Surg (2004) 0.93
The GM-CSF receptor family: mechanism of activation and implications for disease. Growth Factors (2012) 0.93
Smoking related diseases: the central role of monoamine oxidase. Int J Environ Res Public Health (2011) 0.93
Anti-idiotypic antibody mimics proteolytic function of parent antigen. Biochemistry (2007) 0.92
Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia. Am J Clin Nutr (2007) 0.92
Description of tobacco addiction in pregnant women. Eur J Obstet Gynecol Reprod Biol (2005) 0.92
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia. Atherosclerosis (2003) 0.92
Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels. Arterioscler Thromb Vasc Biol (2013) 0.92
Soluble fibre (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: A randomised trial. Atherosclerosis (2010) 0.92
Plant sterols and cardiovascular disease: a systematic review and meta-analysis. Eur Heart J (2012) 0.92
Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability. Paediatr Drugs (2011) 0.91
A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention. J Am Coll Cardiol (2002) 0.91
Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus. PLoS One (2012) 0.90
Elevated CETP activity improves plasma cholesterol efflux capacity from human macrophages in women. Arterioscler Thromb Vasc Biol (2012) 0.89
Parainfluenza virus type 5 (PIV-5) morphology revealed by cryo-electron microscopy. Virus Res (2009) 0.89
Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects. J Lipid Res (2007) 0.89
Role of C-terminal domain and transmembrane helices 5 and 6 in function and quaternary structure of major intrinsic proteins: analysis of aquaporin/glycerol facilitator chimeric proteins. J Biol Chem (2002) 0.89
Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis: systematic review and meta-regression analysis. Atherosclerosis (2010) 0.89
Biorefinery: Toward an industrial metabolism. Biochimie (2009) 0.89
Characteristics of patients with endometriosis in the United States and the United Kingdom. Fertil Steril (2002) 0.89
The French Observational Cohort of Usual Smokers (FOCUS) cohort: French smokers perceptions and attitudes towards smoking cessation. BMC Public Health (2010) 0.89
Lewis-Sumner syndrome and Tangier disease. Arch Neurol (2008) 0.88
Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia. Atherosclerosis (2012) 0.88
Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arterioscler Thromb Vasc Biol (2008) 0.88
Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Am Heart J (2003) 0.88
Malignant phyllodes tumor in an 11-year-old premenarchal girl. J Pediatr Surg (2010) 0.87
First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium. J Magn Reson Imaging (2009) 0.87
Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trials. J Am Coll Cardiol (2003) 0.86
Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer. Urol Res (2004) 0.86
Mosquito (Aedes aegypti ) aquaporin, present in tracheolar cells, transports water, not glycerol, and forms orthogonal arrays in Xenopus oocyte membranes. Eur J Biochem (2003) 0.86
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial. Clin Ther (2010) 0.86
Induction of a protein-targeted catalytic response in autoimmune prone mice: antibody-mediated cleavage of HIV-1 glycoprotein GP120. Biochemistry (2006) 0.85
Hypothyroidism is not associated with increased carotid atherosclerosis when cardiovascular risk factors are accounted for in hyperlipidemic patients. Atherosclerosis (2008) 0.85
Cost effectiveness of full coverage of the medical management of smoking cessation in France. Tob Control (2012) 0.85